EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era
Cheryl Jessen
10 Mar, 2026
Cheryl is a commercial executive with extensive experience in building and scaling high-performing revenue organizations across the pharmaceutical and medical device sectors. She brings a strong track record in driving sustainable growth, leading P&L operations, and supporting strategic transformation initiatives within private equity–backed and high-growth SaaS environments.
Her expertise includes commercial operations, SaaS, and data platform–driven business models, and go-to-market strategy execution. Cheryl is recognized for developing disciplined, metrics-driven revenue strategies and building effective sales organizations from the ground up.
With her experience in revenue leadership and team development, Cheryl contributes to strengthening commercial strategy and supporting scalable growth across life sciences markets.
Other Related Articles
26 Mar, 2026
18 Mar, 2026
10 Mar, 2026
24 Feb, 2026